Aspen, Colo. – At the summer Cosmetic Bootcamp (CBC), Vic Narurkar, M.D., outlined the technological advances and solid research that have made CoolSculpting one of his go-to devices.
Dr. Narurkar said that CoolSculpting’s technological breakthrough and variety of indications make it unique among devices FDA-cleared for noninvasive fat reduction. “Long-term data show that it creates apoptosis and kills fat cells.”
Cryolipolysis cools adipocytes, inducing lipolysis without damaging tissues or other structures. This technological advance creates less trauma than laser, high-intensity focused ultrasound and radiofrequency, all of which result in necrosis, Dr. Narurkar said. Data from his clinical experience with the original CoolSculpting device show results can last 7 years.
Searching PubMed reveals more than 75 published clinical trials involving more than 5,000 patients reported during and after 15 years of CoolSculpting research and development, he added. All this research, plus 7 years’ commercial experience, shows reproducible results, said Dr. Narurkar. “I like to see that my Coolsculpting results are the same as others’ Coolsculpting results.”
With FDA clearance for noninvasive treatment of fat bulges in the submentum, thigh, bra area, abdomen, knee bulges and most recently the arms, he added, CoolSculpting offers the most versatility among noninvasive fat treatments.
Dr. Narurkar is founder and director of the Bay Area Laser Institute, chairman of dermatology at California Pacific Medical Center, San Francisco, and a CBC cofounder and director.
For additional details or to register for future CBC events, please contact:
CBC/Meeting Designs, LLC